Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Grid removals vs. dose and image quality for diagnostic imaging on a Innova 2000 cardiac system.
ISRCTN ISRCTN37477515
ClinicalTrials.gov identifier
Public title Grid removals vs. dose and image quality for diagnostic imaging on a Innova 2000 cardiac system.
Scientific title
Acronym N/A
Serial number at source N0050140299
Study hypothesis Demonstrate a reduction in patient exposure/dose commensurate with no negative impact on diagnosis by removing antiscatter grid.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Coronary artery disease
Participants - inclusion criteria 1. Patients referred for diagnosis of coronary artery disease by coronary angiography . 100 2. BMI <40
Participants - exclusion criteria 1. Risk of pregnancy
2. Patients with suspected valve disease
3. BMI ≥ 40
Anticipated start date 28/01/2004
Anticipated end date 28/07/2004
Status of trial Completed
Patient information material
Target number of participants 100 recruited locally
Interventions Patients referred for diagnosis of coronary artery disease and with a Body Mass Index of less than 40 will be randomised into two groups. One group will receive the standard technique with grid, the other group will receive the modified (lower skin dose) technique without the grid. Post diagnosis images acquired will be double blindly reviewed for image quality.
Primary outcome measure(s) 1. Successful diagnosis of disease
2. Lower skin dose to the patient
3. Lower exposure to members of staff monitored during the trial as the employer is required to do by IRR1999 regulation 8(1)
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Bradford Teaching Hospitals NHS Foundation Trust (UK)
Trial website
Publications No publications intended as of 01/07/10
Contact name Dr  Henry  Lindsay
  Address Bradford Cardiology Research Unit
Ward 22
Bradford Royal Infirmary
Duckworth Lane
  City/town Bradford
  Zip/Postcode BD9 6RJ
  Country United Kingdom
  Tel +44 (0)1274 364 181
  Fax +44 (0)1274 364 741
  Email Steven.lindsay@bradfordhospitals.nhs.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 01/07/2010
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central